March 21, 2017 / 2:06 PM / 9 months ago

BRIEF-aap Implantate 2016 sales and EBITDA below guidance

March 21 (Reuters) - aap Implantate AG:

* Sales by 514,000 euros ($555,993.80) and EBITDA by 450,000 euros slightly below guidance for financial year 2016 due to failure of distributor to fulfil contractual duties

* Announces that in course of drawing up annual financial statements for 2016 management board decided as a precautionary measure to revoke an initial sale with a distribution partner invoiced in financial year

* Reason is a delayed payment of contractual due purchase price

* In continued operation in financial year 2016 sales are at 10.5 million euros and EBITDA at -7.9 million euros and thereby slightly below current guidance Source text for Eikon: Further company coverage: ($1 = 0.9245 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below